These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33818714)

  • 1. Stereotactic body radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
    Li LQ; Zhou Y; Huang Y; Liang P; Liang SX; Su TS
    Hepatol Int; 2021 Jun; 15(3):630-641. PubMed ID: 33818714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes.
    Khorprasert C; Thonglert K; Alisanant P; Amornwichet N
    PLoS One; 2021; 16(9):e0257556. PubMed ID: 34555075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
    Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
    Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy versus lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity matching score analysis.
    Ji X; Zhang A; Duan X; Wang Q
    Radiat Oncol; 2024 Oct; 19(1):143. PubMed ID: 39394613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
    Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
    Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
    Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
    Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram.
    Li X; Ye Z; Lin S; Pang H
    BMC Cancer; 2021 Jun; 21(1):701. PubMed ID: 34126955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.
    Yang JF; Lo CH; Lee MS; Lin CS; Dai YH; Shen PC; Chao HL; Huang WY
    Radiat Oncol; 2019 Oct; 14(1):180. PubMed ID: 31640728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy.
    Matsuo Y; Yoshida K; Nishimura H; Ejima Y; Miyawaki D; Uezono H; Ishihara T; Mayahara H; Fukumoto T; Ku Y; Yamaguchi M; Sugimoto K; Sasaki R
    J Radiat Res; 2016 Sep; 57(5):512-523. PubMed ID: 27053259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Stereotactic Body Radiotherapy to Portal Vein Tumour Thrombus in Hepatocellular Carcinoma: Clinical and Pathological Analysis.
    Kishi N; Kanayama N; Hirata T; Ohira S; Wada K; Kawaguchi Y; Konishi K; Nagata S; Nakatsuka SI; Marubashi S; Tomokuni A; Wada H; Kobayashi S; Tomita Y; Teshima T
    Sci Rep; 2020 Mar; 10(1):4105. PubMed ID: 32139751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?
    Srivastava A; Parambath HK; Ramdulari AV; Saxena H; Kumar R; Pandey S; Shalimar ; Gupta S; Jee B
    Int J Radiat Biol; 2022; 98(10):1495-1509. PubMed ID: 35311612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease.
    Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Song JH
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):209-215. PubMed ID: 32757461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study.
    Ji X; Xu Z; Sun J; Li W; Duan X; Wang Q
    Radiat Oncol; 2023 Jun; 18(1):101. PubMed ID: 37308914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area.
    Im JH; Yoon SM; Park HC; Kim JH; Yu JI; Kim TH; Kim JW; Nam TK; Kim K; Jang HS; Kim JH; Kim MS; Yoon WS; Jung I; Seong J
    Liver Int; 2017 Jan; 37(1):90-100. PubMed ID: 27317941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus.
    Zhang S; He L; Bo C; Yang S; An Y; Li N; Zhao Y; Zhao L; Ma W; Zheng Z
    Radiat Oncol; 2021 Aug; 16(1):149. PubMed ID: 34391452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis.
    Xi M; Zhang L; Zhao L; Li QQ; Guo SP; Feng ZZ; Deng XW; Huang XY; Liu MZ
    PLoS One; 2013; 8(5):e63864. PubMed ID: 23737955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
    Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Sapir E; Tao Y; Schipper MJ; Bazzi L; Novelli PM; Devlin P; Owen D; Cuneo KC; Lawrence TS; Parikh ND; Feng M
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):122-130. PubMed ID: 29066120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis.
    Que J; Wu HC; Lin CH; Huang CI; Li LC; Ho CH
    Medicine (Baltimore); 2020 Mar; 99(13):e19660. PubMed ID: 32221093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.